The analysis of whole genome has revealed specific geographical distribution of 15 Mycobacterium tuberculosis (Mtb) strains across the globe suggestive of unique host 16 dependent adaptive mechanisms in Mtb evolved out of selective pressures. We provide an 17 important correlation of a genome-based mutation to a molecular phenotype across two 18 predominant clinical Mtb lineages of the Indian subcontinent. We have identified a distinct 19 lineage specific mutation-G247C, translating into an alanine to proline conversion in the papA2 20 gene of Indo oceanic lineage 1 [L1] Mtb strains; restoration of cell wall sulfolipids by simple 21 genetic complementation of papA2 from lineage 3 [L3] or from H37Rv (Lineage 4-L4) 22
INTRODUCTION 33
Mycobacterium tuberculosis (Mtb) has the dubious distinction of being one of the most 34 successful human pathogens by virtue of its extreme adaptability and survivability in the face 35 of stress. Being an intracellular pathogen, Mtb has evolved to sense and manipulate the host 36 to its advantage. Whole genome sequencing methods have classified Mtb strains across the 37 globe into 7 major lineages (L1-L7) that have co-evolved with its specific host population and 38 environment (1). 39
The Mtb cell wall is now recognized as a complex entity unique in its composition of 40 complex polyketide lipids like TDM, SL, DAT-PAT, PDIM. This assembly requires a finely 41 tuned array of metabolic functions involving the biosynthesis, maturation, transport and 42 assembly of precursors from the cytoplasm to the exterior (2-5). The ability of Mtb strains to 43 alter their cell wall repertoire to effectively communicate with host cells, modulate immune 44 signalling and play a pivotal role in intracellular fitness is well recognised (6-10). Unique lipids 45 like PGL in Mtb strains are associated with down-regulation of the inflammatory response and 46 consequent hyper-virulence of the strains (11 , 12, 13) . Interestingly, minor modifications like 47 cylopropanation of mycolic acids leads to marked alterations in the host immune activation/ 48 suppression (14, 15) . Mtb has evolved to manipulate the expression of its lipids as a counter 49 for intracellular stress (16, 17) . 50
Sulfolipids represent Mtb specific lipids that have been the focus of research over the last 51 several years (18) (19) (20) . The presence of sulfolipids has been classically associated with 52 virulence of mycobacteria (21) (22) (23) (24) . Moreover, recent evidence has further corroborated their 53 role in bacterial physiology. The biosynthetic pathway of mature sulfolipids in Mtb has been 54 well characterized with the synthesis involving step wise addition of 4 fatty acyl chains to 55 sulfated trehalose by acyl transferases-PapA2 (Rv3820c), PapA1 (Rv3824c) and 56 Chp1(Rv3822) coupled to export of the lipid to the outer cell wall by the transporters-Mmpl8 57 and Sap (3, 25, 26) . 58
In this study, we have employed whole-genome based analysis to pin point the molecular 59 basis of loss of mature sulfolipid expression in the cell wall of the Indo oceanic Mtb lineage (a 60 subset of Mtb lineage 1. We demonstrate that a G247C SNP in the papA2 gene, encoding the 61 first acyl transferase in sulfolipid biosynthesis, results in a detrimental modification of the 62 alanine-83 to proline. Expression of papA2 from H37Rv or N24 (lineage 3) was sufficient to 63 restore mature sulfolipid in the cell walls of deficient strains establishing that this mutation is 64 solely responsible for the loss of sulfolipid in these strains. By using X ray-crystallography, 65
we demonstrate that PapA2 attains a classical NRPS condensation (C) domain architecture 66 with two subdomains arranged in V shape, each with coenzyme-A dependent acyltranferase 67 (CAT) fold, 2 cross-over points and catalytic centre at the interface of two subdomains. The 68 presence of a distinctive Zn finger motif in the N-terminal region of Mtb PapA2 represents a 69 unique modification of this protein from other known acyl transferases. By MD simulation 70 studies of mutant PapA2, we demonstrate that the A83P mutation induces significant 71 misfolding of the protein resulting in global changes in protein conformation. Coupled to our 72 inability to acquire soluble mutant protein from E. coli, we provide evidence for an important 73 role for the surface associated mutation in structural stability of Mtb PapA2 and SL-1 74
biosynthesis. 75

Results
76
Genome sequence analysis provides crucial insight into the loss of mature sulfolipid 77 in lipid scaffold of Lineage 1 Mtb strains. 78
Previous studies (27, 28) have implicated a loss of sulfatides from Mtb strains belonging to 79 South India-(Indo oceanic L1). In order to test if the differences also panned to the other 80 predominant strain of the subcontinent -(L3) in Northern India, we investigated the total cell 81 wall associated lipid content among these two Mtb lineages. Fig.1 shows the 2D TLC lipid 82 profiles of 3 strains each from Mtb lineages 1 and 3. A uniform absence of SL-1 from the apolar 83 lipid fraction was the most distinct feature in all the 3 strains of Indo oceanic L1 Mtb (Fig.1A) . 84
Most of the other apolar or polar lipids were consistent in both the lineages . 85
In an attempt to understand the molecular basis of this sulfolipid loss in (Indo oceanic-L1), we 86 resorted to genome sequence comparison with previously reported L3 strains and the 87 reference strain H37Rv (29). Closer examination of the SNP list pointed towards a common 88 mutation in the Indo oceanic-L1 Mtb genomes (pos. 428579); this G to C conversion resulted 89 in conversion of the 83 rd alanine of PapA2 (a polyketide associated acyl transferase involved 90 in sulfolipid biosynthesis of Mtb) to proline (Fig. 1C) ; a non-tolerable mutation to protein 91 function and structure (SIFT analysis). Interestingly, this mutation was not observed in M. 92 canetti or the other closely related L1 strain -T83 (belonging to the Vietnam region) indicating 93 significant specificity of this mutation to the Indian subcontinent (Fig. 1C) ; consequently, T83 94 strain was capable of producing mature SL-1 in the cell wall associated non-polar lipid fraction 95 ( Fig. 1D) . 96
Trans-complementation of papA2 from L3 genome restores SL-1 biosynthesis in 97
representative L1 strain 98
The presence of a deleterious non-synonymous mutation, A83P, only in PapA2 allowed us to 99 hypothesise its association with the absence of SL-1 in Indo oceanic lineage-1. In order to test 100 this hypothesis, we ectopically expressed HA-tagged papA2 gene from H37Rv or L3 in the 101 Indo oceanic L1 strain-N73 and confirmed expression by tag specific immunoblotting (Fig. 102 2A) . We checked for the restoration of SL-1 biosynthesis by 1D as well as 2D -radiometric but not when papA2 of Indo oceanic L1 or in case of vector control were used ( Fig. 2B ). Similar 105 restoration of SL-1 in another Indo oceanic L1 strain -N70 explicitly confirms the causative 106 role of A83P mutation in the loss of PapA2 function and consequent SL-1 in this subset of L1 107
Mtb strains. 108
To test if this mutation affected the structural integrity of PapA2 or its function, we expressed 109 both the Wt and mutant proteins in E. coli. While we could obtain ~ 50% soluble protein 110 expression of the Wt, the mutant protein partitioned to insoluble fractions in all conditions of 111 culture and expression ( Fig. 2C ) suggestive of a strong influence of the mutation on overall 112 protein structure of PapA2. We resorted to a 2-step approach to confirm the role of this 113 mutation in protein structure-1) establish structure of the Wt protein and 2) understand the 114 effect of A83P substitution by molecular dynamics simulation. A significantly pure in excess of 115 90% of native PapA2 in the monomeric state ( Fig. 2F , G) was subjected to X-ray 116 crystallography for determination of structure after confirming the veracity of the purified 117 protein by MALDI-TOF mass spectrometry ( Fig. S1 ). 118
PapA2 structural features display an unusual NRPS C domain architecture 119
The structure of PapA2 was determined at resolution of 2.16 Å using the phase calculated 120 from anomalous diffraction of selenium as described in Methods (PDB ID-6AEF). Details of 121 data collection and data processing are summarized in Table 2 . The asymmetric unit possess 122 two molecules ( Fig. 3A) . Each monomeric structure can be further described by dividing the 123 protein into two subdomains: an N-terminal subdomain (residues 2-215) and a C-terminal 124 subdomain (residues 216-459), each with a classical CAT fold comprising of a large β sheet 125 flanked by alpha helices (Fig. 3B ). The core β sheet in the N-terminal subdomain 126 encompasses seven mixed type beta strands (parallel and antiparallel) -β1, β2, β3, β6, β7, β8 127 and β13 whereas the C-terminal subdomain contains six mixed beta strands -β9, β10, β11, β12, 128 β14 and β15 (Fig. 3B ). The two subdomains are connected by two cross-over points -129 "latches", wherein the C-terminal subdomain extends back to the N-terminal subdomain -1) 130 "N-terminal latch" -residues 311-323, forming helix-α14 and 2) "C-terminal latch" -residues 131 391-411, including helix-α18 followed by a beta strand-β13 ( Fig. 3B ). Most importantly, 132 structure analyses indicated the presence of a unique Zn binding motif (ZnF) in the N-terminal 133 subdomain comprising of residues-C19, H21, H124, H135 (Fig. 3C) . The presence of Zn in 134 the native protein was further confirmed through ICP-MS. 135
The interface region of PapA2 possess substrate binding sites 136
Solid surface analysis revealed the presence of a solvent accessible tunnel at the interface of 137 two subdomains ( Fig. 4A ). Placement of pseudo-tunnel at the interface of two subdomains 138 using Caver program (30) and metapocket server (31) showed H166, the catalytic centre (32), 139
in the middle of the tunnel indicating a potential substrate binding site(s). This ~ 25 Å long 140 tunnel originated close to the "N-terminal latch" and ended before helix 3 with an access to 141
His166 from both ends will henceforth be referred to as the "tunnel" (Fig. 4B) . 142
Further detailed analysis revealed a well-organized arrangement of residues with distinct 143 polarity at the "interface" tunnel with a dense population of positively charged arginine residues 144 in the tail region of the tunnel and a more diverse distribution of residue polarity in the head 145 region of the tunnel (Fig. 4C ). Interestingly, another cavity enriched in hydrophobic residues 146 at one end (the "hydrophobic tunnel") intersects with the tunnel in close proximity to the 147 catalytic H166 suggesting a putative binding site for the large hydrophobic acyl chain of the 148 donor substrate. 149
Molecular docking provides evidence for a unique substrate approach to PapA2 150
We further investigated the interface region by molecular docking using the acceptor and 151 donor substrates. We reasoned that the catalytic H166 should be in close proximity of the 152 acylation site of the substrate for efficient catalysis. Using this as a reference, we selected the 153 conformer that positioned the 2'-OH of Trehalose-2-Sulfate in the proximity of H166 and also 154 identified 4 residues-P171, T307, T324 and-S384 in apposition of the ligand ( Previous studies have identified the key acceptor substrate determinants for some of these 169 proteins by mutagenesis (34, 37, 38) . Our docking studies identified important residues of the 170 head region of the solvent accessible tunnel -P171, T307, T324, S384 residing in close 171 proximity of the acceptor substrate ( Fig. 5A) . Surprisingly, mapping with the other C-domain 172 proteins revealed three of four residues of Mtb PapA2 (P171, T324 and S384) as positional 173 equivalents of acceptor substrate determinants in VibH (G131 and N335) or CDA-C1 (G162, 174 S309) or PapA5 (G129) ( Table 3) . 175
MD simulations reveal putative local and global changes in A83P-mutant 176
PapA2.
177
MD Simulations have been extensively used in the past to understand intrinsic dynamics 178 behaviour for various proteins. Together with crystallographic data, this complementary 179 approach captures dynamics and structural insights of protein conformational state. To 180 generate the starting structure of mutant, we modelled the A83P residue site of PapA2 181 structure ( Fig. 6A) . Interestingly, the mutation is distal to other functional sites, including ZnF 182 motif and catalytic motif, and was mapped to the protein surface (α4 helix) ( Fig. 6B ). Two 183 independent MD simulations of the wild-type and mutant PapA2 were performed for a cumulative 1 μs simulation time. Standard MD protocol, including all-atomistic representation was used (see Methods for details). 186
Comparison of wild-type and mutant trajectories revealed a large number of global structural 187 rearrangements ( Fig. 6C-D) . The order parameters, RMSD and Rg capture the mobility and 188 overall compactness of the protein, respectively. The mutant simulations showed increased Concomitant to global changes, we also monitored local dynamical changes induced by the 195 mutant residue. Analysis of neighbouring residues that directly contact residue 83 of PapA2 196 identified major alterations. Local contacts were significantly reduced for the α4-α6, α4-α2 197 and β3-latch regions with increase in contacts the α4-β7 region as a result of the proline 198 mutation in mutant PapA2 (Fig. 6E ). In addition, while A83 bonded with H87, M80, A86, and 199 A79 via hydrogen bonds, analysis of the P83 interactions significantly reduced the local 200 network to specifically two bonds (H87, and A86) ( Fig. 6F, G) , lending further support to the 201 substantial local destabilization of non covalent interactions that serves as nucleation site to 202 unfold the protein (the global change) and affect overall protein stability. 203
Discussion
204
The mycobacterial cell wall is one of the most complex chemical entities replete in lipid and 205 carbohydrate moieties not found elsewhere in biological systems apart from actinomycetes. 206
The intricate molecular mechanisms for the biosynthesis, maintenance and plasticity is yet not 207 well understood; more so the adaptability in the face of physiological stress and environmental 208 pressures. Given the long evolution of Mtb, its adaptation with the human host in the context 209 of its genomic and molecular repertoire is now being recognised as an important factor for the 210 successful survival. Recent molecular evidences have pointed out lineage specific variations 211 in Mtb, culminating as a result of both host driven and environmental cues, correlating with the 212 inflammatory potential of the pathogen (1, 39, 40) . Often, a clear correlation between the 213 observed lineage specific genetic attributes and its molecular / phenotypic characteristics or 214 vice versa remains poorly characterized. 215
In an effort to understand the molecular basis for loss of sulfolipid in clinical strains of Mtb (a 216 small subset of Mtb lineage 1), we identified a single SNP in the deficient strains mapping to 217 the PapA2 coding region of the genome. This resultant conversion of the 83 rd alanine to proline 218 of PapA2, one of the primary enzymes of the mycobacterial sulfolipid biosynthetic machinery 219 manifested as a compromise in protein stability and folding, significant enough to prevent our 220 attempts to obtain purified, soluble mutant protein even by chemical chaperones. This global 221 defect in the fold of the mutant protein was further supported by MD simulation studies and 222 emphasizes a crucial role for the A83 residue in structural integrity of PapA2. 223
In agreement with the structure of other C domain multidomain peptide synthases proteins of 224 NRPS (non-ribosomal peptide synthases) (33, 34, 36, 37) , PapA2 also conformed to a typical 225 V shaped two subdomain containing architecture with two latch components and catalytic 226 histidine at the interface of two subdomains. The distinct presence of a solvent accessible 227 tunnel in close apposition with the catalytic site and a hydrophobic tunnel implies a dual 228 substrate approach strategy-an acceptor substrate (T2S) approaching from the head region 229 and the donor acyl CoA substrate from the tail region (acyl group residing in the hydrophobic 230 rich region) and the CoA in close proximity of the tail region. Remarkably, the A83P mutation 231 mapped to the protein surface away from the catalytic and Zinc finger containing regions (20 232 Ǻ and 13 Ǻ respectively) of L1 PapA2. Our conclusion of mutation site distant from the active 233 site deteriorates protein structure and function is in agreement with the reports on the effect 234 of distant mutation in the proteins (41, 42) . Interestingly, the occurrence of hydrophobic 235 residues, such as Ala or Val, in this position is highly conserved in all the members of the PapA proteins of Mtb suggestive of the importance of this Ala residue in the function of this 237 protein family (Fig. 7) . 238
The most interesting aspect of the structure was the identification of a putative Zn finger motif 239 in PapA2. Presence of this motif implores the possibility of protein-protein/ protein -DNA 240 interactions unique to any of the acyl transferase proteins identified till date. While PapA2 is 241 involved in the first acylation of T2S, PapA1 catalyses the addition of a second acyl chain to 242 this mono-acylated sulphated trehalose. We identified a long hydrophobic tunnel that could 243 house the acyl CoA donor necessary for PapA2 function. However, PapA1 function requires 244 2 acyl chains to be fitted in close proximity of each other (acyl group of mono-acylated -T2S 245 and the second fatty acyl CoA). It is logical to assume the possibility of an interaction between 246
PapA2 and PapA1 in order to facilitate this dual acyl chain transfer. The presence of the Zn 247 finger motif in native PapA2 strongly suggests a similar protein-protein interaction in 248 mycobacterial sulfolipid biosynthesis. In fact, previous studies have proposed a similar multi (44). While the importance of sulfolipid in host-pathogen cross talk can be envisaged given 261 its localization to outer most layer of the cell, it has also been implicated in inhibition of phago-262 lysosome fusion (21) and modulating the pro-inflammatory response (22, 23) . Alternatively, by functioning as a sink to buffer changes in propionyl CoA content SL can contribute to 264 metabolic reshuffling during in-vivo growth (16, 45, 46) . In contrast, mutants of H37Rv that lack 265 sulfolipids viz. pks2, mmpl8 have not shown any defect in in vivo growth in mice models of 266 infection (7, 47). Given the pleomorphic importance of PGL in Mtb virulence and its 267 dependence on the strain genotype, it is plausible to expect that this specific loss of sulfolipid 268 -1 in the Indo-oceanic L1 strains specifically is an adaptive mechanism for the fine-tuned (Table S1 ) were a kind 280 gift of Dr. Sebastien Gagneux, Swiss TPH and part of the San Francisco collection (1). E. coli 281 strains were cultured as per standard procedures in LB broth or agar (BD Biosciences, USA). 282
Media was supplemented with kanamycin (50μg /ml) or carbenicillin (100μg/ml) when needed. 283
Analysis of lipids from Mtb 284
10 ml Mtb grown to the logarithmic phase in 7H9 media was supplemented with 1 µCi of 14 C-285 acetate (American Radiolabeled Chemicals, Inc. USA) for 24h at 37 0 C following which the 286 polar and apolar lipids were isolated according to standard protocols (43). The extent of 287 radiolabel incorporation was estimated by using TopCount NXT scintillation counter 288 (PerkinElmer, Ohio, USA). Lipids equivalent to 10000 cpm for all the three strains were spotted 289 on TLC silica gel 60 (Merck Millipore, USA) and eluted using solvents (A-D) for apolar lipids 290 and (D, E) for polar lipids (43). The TLCs were developed onto X rays or scanned using GE 291
Typhoon FLA 7000 phosphorimager system (GE Healthcare Bio-Sciences, USA). 292
Cloning, Expression and Purification of Mtb-PapA2 293
For mycobacterial expression of PapA2, the complete ORF of papA2 was PCR amplified from 294 the genomic DNA of H37Rv (R), N24 (L3) or N73 (L1) and cloned into the mycobacterial 295 expression vector pMV261 by using specific primers-A2F and A2R to express the recombinant 296 protein as a HA tagged fusion protein. For expression in E. coli, papA2 was amplified from the 297 genomic DNA of H37Rv (Wt PapA2) or N73 (mutant PapA2) using primers A2expF and 298
A2expR, cloned into pET28-SMT3 vector to obtain the plasmid pVIP06. A list of primers is 299 given in Table 1 Expression of PapA2 was confirmed by immunoblotting with Tag specific antibody-(ab18181-310 HA/ ab18184-His, Abcam, UK). 311
Sample preparation and MALDI-TOF mass spectrometry 312
For MALDI-TOF, 25µg of PapA2 protein subjected to trypsin digestion was injected into the 313 MALDI-TOF mass spectrometer-in a MALDI-TOF/TOF 5800 (AB Sciex, USA) and the 314 fragments were identified from SwissProt. 315
Protein crystallization
Sparse matrix crystallization trials of PapA2 (at 10 mg/ml) were carried out with Crystal Screen 317 HT (Hampton research, CA, USA) by Hanging drop vapour diffusion technique (48) at 25 0 C. 318
Initial diffraction experiments were performed using crystals obtained in 0.2 M MgCl2·4H2O, 319 0.1 M C2H12AsNaO5·3H2O, pH 6.5, 20 % w/v PEG 8,000 buffer. Following further optimization, 320 the crystals were stored frozen with with 30 % w/v PEG 8,000 as a cryoprotectant. 321
Data collection and processing 322
Diffraction data for native PapA2 and SeMet-PapA2 crystals were collected at European 323 Synchrotron Radiation Facility (ESRF, Grenoble, France) on the beam line BM14. PapA2 and 324
SeMet-PapA2 crystals were diffracted up to 2.16 Å and 2.49 Å resolutions, respectively. Data 325 obtained were Indexed and scaled using the program HKL-2000 (49) . The scaled intensities 326 were converted to structure factors using the program TRUNCATE (DOI-327 10.1107/S0567739478001114) as implemented in CCP4 (50). The phase problem was solved 328 using the selenium as heavy atoms and by applying Single Anomalous Dispersion (SAD) 329 phasing procedure using AutoSol wizard in PHENIX (51, 52). The structure of PapA2, was 330 determined by Molecular replacement (53) using chain (B) of SeM-PapA2 as template in 331 Phaser (54) in PHENIX, refined as rigid body followed by restraint refinement using 332 phenix.refine (55). The model was built into the electron density map using the program 333 COOT (56). The program PyMOL (PyMOL Molecular Graphics System, Schrödinger, LLC) 334 was used to visualize and analyse the model. 335
Molecular Dynamic Simulation 336
The crystal structure of papA2 was cleaned and prepared using Maestro (Schrödinger) 337 (Maestro, version 9.8, Schrödinger, LLC, New York, NY, 2014). The prepared structure was 338 selected for generation of mutation, A83P, using Accelrys Discovery Studio visualizer 339 (Discovery Studio. "version 2.5." Accelrys Inc.: San Diego, CA, USA (2009). Both the Wt and 340 mutant PapA2 structures were taken up for further refinement by molecular dynamics (MD) 341 simulations by GROMACS and OPLS-all atom force field (DOI-10.1021/ja9621760) using Wt 342 papA2 as the starting structure. Both structures were used for separate MD simulations for 343 1μs each. Each of the starting structure was placed in a cubic box solvated using TIP4P water 344 representation (DOI-10.1080/00268978500103111) (see Table 4 ). The systems were 345 neutralized using Na+ ions. The starting structures were subjected to energy minimization 346 using the steepest descent method. Systems were simulated at 300K using Nose-Hoover T-347 coupling (DOI-10.1063/1.447334) and then later subjected to Parrinello-Rahman barostat 348 (DOI-10.1063/1.328693) for pressure coupling at 1 bar, before the production run were 349 started. Electrostatic interactions were calculated using the particle mesh Ewald (PME) 350 summation (DOI-10.1063/1.464397). 351
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C) The putative Zn finger motif is shown-Zn atom (red circle) and coordinating residues (grey). The MALDI-TOF spectra of purified PapA2 is shown. The peak at the expected molecular mass of 643 52kda confirms the identity of the protein. 
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